Skip to content
The Chat Archive
gpt-4.1-mini-2025-04-14· OpenAI WildChat-4.8M (AI2)

Is Fasoracetam the same as Phenylpiracetam Hydrazide?

  1. User

    Is Fasoracetam the same as Phenylpiracetam Hydrazide?

  2. Assistant

    No, Fasoracetam and Phenylpiracetam Hydrazide are not the same compound. They are distinct substances with different chemical structures and properties.

    • Fasoracetam is a member of the racetam family of nootropic compounds. Its chemical structure is different from that of Phenylpiracetam and its derivatives. Fasoracetam is known for its potential cognitive-enhancing effects primarily through modulation of glutamate receptors and possibly cholinergic systems.

    • Phenylpiracetam Hydrazide is a derivative of Phenylpiracetam, which itself is a modified version of Piracetam with a phenyl group added. The hydrazide form involves a chemical modification where a hydrazide group is attached, altering its pharmacological profile. Phenylpiracetam is known for its stimulant and cognitive-enhancing effects, and its hydrazide derivative is a distinct chemical entity from Fasoracetam.

    In summary, while both belong broadly to the racetam-related group of nootropics, Fasoracetam and Phenylpiracetam Hydrazide are different chemicals and should not be considered the same.

  3. User

    Give me a concise overview of the research on IDRA-21... specifically its benefits, potentials, etc

  4. Assistant

    IDRA-21 is a nootropic compound classified as an ampakine, known for its ability to positively modulate AMPA-type glutamate receptors in the brain. Research on IDRA-21 suggests the following:

    • Cognitive Enhancement: It has been shown to improve learning and memory in animal models, particularly in tasks involving spatial memory and object recognition.

    • Neuroprotective Potential: By enhancing synaptic plasticity, IDRA-21 may help counteract cognitive deficits caused by neurological disorders or brain injury.

    • Mechanism of Action: It acts as a positive allosteric modulator of AMPA receptors, which enhances excitatory neurotransmission and synaptic efficiency without directly activating the receptor.

    • Therapeutic Prospects: Studies have explored its potential for treating conditions such as Alzheimer's disease, age-related cognitive decline, and possibly schizophrenia.

    • Safety and Tolerability: Preclinical data suggest low toxicity and good tolerability, but human clinical data remain limited.

    Overall, IDRA-21 shows promise as a cognitive enhancer and neuroprotective agent, but more extensive clinical research is required to confirm its efficacy and safety in humans.

  5. User

    Give me a concise overview of the research on Dihexa... specifically its benefits, potentials, etc

  6. Assistant

    Dihexa (also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small peptide compound developed for its neurotrophic and cognitive-enhancing properties. Research highlights include:

    • Cognitive Enhancement: Dihexa has been shown to improve learning, memory, and synaptic connectivity in animal models, including models of neurodegeneration and brain injury.

    • Neurotrophic Activity: It acts by promoting the activation of hepatocyte growth factor (HGF) and its receptor c-Met, supporting synaptogenesis, neuronal growth, and brain repair.

    • Potential Therapeutic Uses: Dihexa shows promise for treating neurodegenerative diseases like Alzheimer's, traumatic brain injury, and other cognitive impairments by restoring synaptic function.

    • Mechanism of Action: Unlike many nootropics, Dihexa directly enhances synaptic architecture and function through growth factor signaling pathways.

    • Safety: Preliminary animal studies suggest good tolerability, but human clinical trials are limited or ongoing, so safety and efficacy in humans are not fully established.

    In summary, Dihexa is a novel neurotrophic compound with strong preclinical evidence for enhancing cognition and promoting brain repair, holding potential for treating neurodegenerative and cognitive disorders pending further clinical validation.

  7. User

    Give me a concise overview of the up-to-date research on Noopept... specifically its benefits, potentials, etc

  8. Assistant

    Noopept is a synthetic nootropic peptide reputed for cognitive enhancement and neuroprotective properties. Current research highlights include:

    • Cognitive Benefits: Animal and some human studies suggest Noopept may improve memory, learning, attention, and information processing, possibly more potent than classical racetams.

    • Neuroprotection: It exhibits antioxidant and anti-inflammatory effects, protecting neurons from oxidative stress and excitotoxicity, which may help in neurodegenerative conditions.

    • Mechanism of Action: Noopept modulates glutamatergic transmission, enhances expression of neurotrophic factors like BDNF and NGF, and may improve synaptic plasticity.

    • Potential Therapeutic Uses: Investigated for mild cognitive impairment, Alzheimer's disease, stroke recovery, and traumatic brain injury, with some positive preclinical and limited clinical findings.

    • Safety Profile: Generally well-tolerated with low toxicity in animal studies; human safety data are limited but suggest mild side effects when taken appropriately.

    Overall, Noopept shows promising cognitive-enhancing and neuroprotective effects, but more rigorous clinical trials are needed to confirm efficacy and safety in humans.

  9. User

    Which are currently known or considered or observed to be the most stimulating racetams that also have a low toxicity and low side-effect profile?

  10. Assistant

    The racetams generally considered to be the most stimulating while maintaining a relatively low toxicity and side-effect profile include:

    1. Phenylpiracetam

    • Stimulation: Known for notable psychostimulatory effects, including increased physical energy, alertness, and cognitive enhancement.
    • Toxicity/Side Effects: Generally well tolerated; occasional reports of overstimulation, irritability, or insomnia at higher doses.
    • Use: Popular for both cognitive enhancement and mild physical stimulation.

    2. Aniracetam

    • Stimulation: Provides mild to moderate stimulation with anxiolytic properties, improving mood and focus without excessive jitteriness.
    • Toxicity/Side Effects: Low toxicity; some users report mild headaches or gastrointestinal discomfort.
    • Use: Favored for mood enhancement and cognitive clarity.

    3. Pramiracetam

    • Stimulation: Considered stimulating, especially in terms of focus, memory, and mental energy without the jitteriness associated with stimulants.
    • Toxicity/Side Effects: Low toxicity with occasional mild headaches or irritability; generally well tolerated.
    • Use: Often used to boost concentration and memory.

    Notes on Safety:

    • General Safety: Racetams as a class typically have low toxicity and a good safety profile, but individual reactions vary.
    • Choline Supplementation: Many racetams are advised to be taken with a choline source (e.g., alpha-GPC, CDP-choline) to reduce headaches and optimize effects.
    • Limited Long-term Data: Most data come from animal studies and anecdotal reports; long-term human studies are limited.

    Summary:

    Phenylpiracetam is generally regarded as the most stimulating racetam with low toxicity, followed by Pramiracetam and Aniracetam, which provide stimulating effects with additional mood benefits and low side effects. As always, start with low doses and monitor individual tolerance.